Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950103-24-013563
Filing Date
2024-09-13
Accepted
2024-09-13 16:16:24
Documents
6
Period of Report
2024-11-11

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A dp217958_pre14a.htm PRE 14A 111244
2 GRAPHIC image_001.jpg GRAPHIC 4159
3 GRAPHIC image_002.jpg GRAPHIC 132241
4 GRAPHIC image_003.jpg GRAPHIC 134119
5 GRAPHIC image_004.jpg GRAPHIC 107440
6 GRAPHIC image_005.jpg GRAPHIC 256498
  Complete submission text file 0000950103-24-013563.txt   986707
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39071 | Film No.: 241297948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)